INOVIO to Participate in Upcoming Investor Conferences
INOVIO (NASDAQ: INO) will participate in the Jefferies Global Healthcare Conference in London and Piper Sandler’s healthcare conference in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
INOVIO (NASDAQ: INO) will participate in the Jefferies Global Healthcare Conference in London and Piper Sandler’s healthcare conference in New York.
The Jefferies presentation is November 18 at 12:00 p.m. EST / 5:00 p.m. GMT. The Piper Sandler fireside chat is December 1 at 2:00–2:25 p.m. EST. Management will also hold one-on-one investor meetings during the conferences. Webcast replays will be available for 90 days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Jefferies Global Healthcare Conference in
Date: Wednesday, November 18
Time: 12:00 p.m. EST / 5:00 p.m. GMT
Format: Presentation
Webcast: https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/e3gFZPzHNgoxtsxeAwXEr2
Piper Sandler 38th Annual Healthcare Conference in
Date: Tuesday, December 1
Time: 2:00-2:25 p.m. EST
Format: Fireside chat
Webcast: https://event.webcasts.com/starthere.jsp?ei=1782025&tp_key=9cacd40318
Replays of the presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.
About INOVIO
INOVIO is a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that enable the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com and follow us on LinkedIn and X (formerly known as Twitter).
Contacts
Media: Josephine Galatioto - ICR Healthcare, inoviopr@icrhealthcare.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, peter.vozzo@icrhealthcare.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-302935927.html
SOURCE INOVIO Pharmaceuticals, Inc.